End-to-end U.S. capital-markets advisory.
U.S. IPO, Listing & Uplisting
Going public and uplisting onto Nasdaq, NYSE, and OTC Markets — listing readiness, structuring, and ongoing listing regulatory advisory.
Reverse Takeover & SPAC / De-SPAC
Alternative routes to a U.S. listing — reverse takeovers and SPAC / de-SPAC transactions, with Rule 144 holding-period and lock-up mechanics handled with precision.
SEC Reporting & US GAAP
Post-listing compliance — SEC reporting support (10-K, 20-F, 6-K, 8-K), US GAAP advisory, and audit readiness for newly public companies.
Capital Raising, ATM & IR
At-the-market (ATM) programmes, direct funding, mergers and acquisitions, and investor relations for listed and pre-listing companies.
Representative of our work across listing routes.
Advised on the uplisting of an OTC-traded issuer onto a U.S. national exchange.
Supported a publicly traded issuer to a market capitalisation of approximately US$350 million.
Executed the disposition of an OTC-listed corporate shell vehicle.
Advising a U.S.-listed issuer on a US$200 million at-the-market (ATM) equity programme.
Illustrative of engagements undertaken. Client identities are held in confidence.
How we work.
By introduction only.
Bluesky Advisory Group accepts engagements through trusted referral. For introductions and counsel enquiries:
enquiries@blueskysolutionsmy.com